|
Search for our Investigators on Pub
Med
|
PATRICIA A. WOOD, M.D., Ph.D.
Lab
LAB PERSONNEL
Pat Wood, M.D., Ph.D. - Associate Professor, USC;
Chief, DVAMC
PUBLICATIONS
Wood PA, Yeh M, Pan D, Lambros KM, McCabe KM, Hough RL.
Exploring the relationship between race/ethnicity, age of
first school-based services utilization, and age of first
specialty mental health care for at-risk youth. Ment Health
Serv Res. 2005 Sep;7(3):185-96.
Wood PA, Bove K, You S, Chambers A,
Hrushesky WJ. Cancer growth and spread are saltatory and
phase-locked to the reproductive cycle through mediators of
angiogenesis. Mol Cancer Ther. 2005 Jul;4(7):1065-75.
Wood PA, Hrushesky WJ. Sex cycle modulates cancer growth.
Breast Cancer Res Treat. 2005 May;91(1):95-102.
You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky
WJ. Daily coordination of cancer growth and circadian clock
gene expression. Breast Cancer Res Treat. 2005
May;91(1):47-60.
Hazen AL, Hough RL, Landsverk JA, Wood PA. Use of mental
health services by youths in public sectors of care. Ment
Health Serv Res. 2004 Dec;6(4):213-26.
Leslie LK, Weckerly J, Landsverk J, Hough RL, Hurlburt MS,
Wood PA. Racial/ethnic differences in the use of
psychotropic medication in high-risk children and
adolescents. J Am Acad Child Adolesc Psychiatry. 2003
Dec;42(12):1433-42.
Leslie LK, Hurlburt MS, Landsverk J, Rolls JA, Wood PA,
Kelleher KJ. Comprehensive assessments for children entering
foster care: a national perspective. Pediatrics. 2003
Jul;112(1 Pt 1):134-42.
Garland AF, Aarons GA, Brown SA, Wood PA, Hough RL.
Diagnostic profiles associated with use of mental health and
substance abuse services among high-risk youths. Psychiatr
Serv. 2003 Apr;54(4):562-4.
Bove K, Lincoln DW, Wood PA, Hrushesky WJ. Fertility cycle
influence on surgical breast cancer cure. Breast Cancer Res
Treat. 2002 Sep;75(1):65-72.
Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy
for gynecological and genitourinary cancers. Chronobiol Int.
2002 Jan;19(1):237-51.
Wood PA, and Hrushesky W. Circadian timing of cancer
chemotherapy. In: The Chemotherapy Source Book, 3rd ed,
Perry, MC (ed), Chapter 12, Williams and Wilkins, Baltimore,
2001.
Lincoln DW, Hrushesky WJM, Wood PA. Circadian organization
of thyhmidylate synthase activity in normal tissues: a
possible basiks for 5-fluorouracil chronotherapeutic
advantage. Int J Cancer 88:479-485, 2000.
Bjarnason GA, Jordan RCK, Wood PA, Li Q, Lincoln D, Sothern
RB, Hurshesky WJM, Ben-David Y. Circadian expression of
clock genes in human oral mucosa and skin: association with
specific cell cycle phases. Amer J Pathol 158:1793-1801,
2001.
Hrushesky WJM, Vyzula R, Wood PA. Fertility maintenance and
5-Fluorouracil timing within the fertility cycle.
Reproductive Toxicology 13:413-420, 1999.
Wood PA, Hrushesky WJM and Klevecz R. Distinct circadian and
time structures characterize myeloid and erythroid
progenitor and multiprogenitor clonogenicity as well as
marrow precursor proliferation dynamics. Exp Heamtol
26:523-533, 1998.
Tzannis, S.T., Hrushesky, W.J.M., Wood, P.A. and Przybycien,
T.M. Adsorption of a formulated protein on a drug delivery
device surface. J Colloid Interface Science 189:216-228,
1997.
Hrushesky, WJ and Wood, PA. Circadian time structure of
septic shock: timing is everything. (Letter to the Editor) J
Infectious Disease, 175:1283-1284, 1997.
Wood, PA and Hrushesky, WJM. Circadian rhythms and cancer
chemotherapy. Critical Reviews in Eukaryotic Gene Expression
6(4):299-343, 1996.
Wood, P.A. and Hrushesky, W.J.M. Circadian timing of cancer
chemotherapy. In: The Chemotherapy Source Book, 2nd edition,
Perry M.C. (ed), Chapter 12, pp 177-202, Williams and
Wilkins, Baltimore, 1996.
Hrushesky, W.J.M., Marsh, R. de W. and Wood, P.A. Circadian
pharmacodynamics. In: Principles of Antineoplastic Drug
Development and Pharmacology, Schilsky, R.L., Milano, G.A.,
Ratain, M.J. (eds), Chapter 31, pp 681-720, Marcel Dekker
Inc, New York 1996.
Tzannis, S.T., Hrushesky, W.J.M., Wood, P.A. and Przybycien,
T.M. Irreversible inactivation of interleukin-2 in a
pump-based delivery environment. Proc. Natl. Acad. Sci USA
93:5460-5465, 1996.
Wood, PA and Hrushesky, W.J.M. Biological perspectives on
circadian cancer therapy. J Infusional Chemotherapy
5:182-190, 1995.
Wood, P.A. and Hrushesky, WJM. Erythropoietin usage in
patients with cancer. The Cancer Journal, Scientific
American, 1:243-246, 1995.
Hamilton, S.R., Liu, B., Parsons, R.E., Papadopolous, N.C.,
Jen, J., Powell, S.M., Krush, A.J., Berk, T., Cohen, Z.,
Tetu, B., Burger, P.C., Wood, P.A., Taqi, F., Booker, S.V.,
Peterson, G.M., Offerhaus, G.J.A., Tersmette, A.C.,
Giardiello, F.M., Vogelstein, B. and Kinzler, K.W. The
molecular basis of Turcot's syndrome. N Engl J Med
332:839-846, 1995.
Wood, P.A. and Hrushesky, W.J.M. Cisplatin-associated
anemia: An erythropoietin deficiency syndrome. J Clin Invest
95:1650-1659, 1995.
Wood, P.A. Chronotherapy of Growth Factors J. Infusional
Chemotherapy. 5(1):20-23, 1995.
Hrushesky, W.J.M., Langevin, T., Kim, Y.J. and Wood, P.A.
Circadian dynamics of tumor necrosis factor-a (cachectin)
lethality. J Exp Med. 180:1059-1065, 1994.
Tzannis, S.T., Przybycien, T.M., Hrushesky, W.J.M. and Wood,
P.A. The impact of formulated interleukin-2/delivery device
surface interactions on bioefficacy. In: Biomaterials for
Drug and Cell Delivery, eds. Mikos, A.G., Murphy, R.,
Bernstein, H. and Peppas, N.A. Materials Research Society
Symposium Proceedings. 331:227-232, 1994.
Wood, P.A. and Hrushesky, W.J.M. Chronopharmacodynamics of
hematopoietic growth factors and antitumor cytokines. In:
Circadian Cancer Chemotherapy. Hrushesky WJM (ed.), CRC
Press, Florida, pp. 185-207, 1994.
Wood, P.A., Vyzula, R., and Hrushesky, W.J.M. Circadian
hematopoietic growth factor chronotherapy. J Infusional
Chemotherapy 3(3):110-116, 1993.
Wood, P.A. and Eaton, J.W. Hemoglobin catabolism and
host-parasite heme balance in chloroquine-sensitive and
chloroquine-resistant Plasmodium berghei infections. The Am
J Trop Med Hyg 48(4):465-472, 1993.
Hrushesky, W.J.M., Martynowicz, M., Markiewicz, M.,
Roemeling, Rv., Wood, P.A. and Sanchez de la Peņa, S.
Chronotherapy of cancer: a major drug-delivery challenge.
Advanced Drug Delivery Reviews 9:1-83, 1992.
Wood P.A., Sanchez de la Pena, S. and Hrushesky, W.J.M.
Evidence for circadian dependency of recombinant human
erythropoietin (rhEPO) response in the mouse. In: Temporal
Control of Drug Delivery, W.J.M. Hrushesky, R. Langer and F.
Theeuwees (eds.), Ann NY Acad Sci, 618:610-612, 1991.
Roemeling Rv., DeMaria L., Salzer M., Connerty M., Wood
P.A., Portuese E., Sanchez de la Pena S., DeConti R.C.,
Chikkappa G., Pasquale D., Ferro T., and Hrushesky W.J.M.
Circadian stage dependent response to IL-2 in mouse spleen
and bone marrow. In: Ann Rev Chronopharmacology Vol 7,
Reinberg, A., Smolensky, M. and Labrecque, G. (eds) Pergamon
Press, New York pp 211-214, 1990.
Wood, P.A., Sanchez de la Peņa, S. and Hrushesky, W.J.M.
Circadian timing of recombinant human erythropoietin (rhEPO)
in the mouse affects hematopoietic response. In: Ann Rev
Chronopharmocology Vol 7, Reinberg, A., Smolensky, M. and
Labrecque, G. (eds) Pergamon Press, New York pp 173-176,
1990.
Hrushesky, W.J.M., Roemeling, Rv., Wood, P.A., Langevin, T.R.,
Lange, P. and Fraley, E. High-dose intensity,
circadian-timed doxorubicin and cisplatin adjuvant
chemotherapy for bladder cancer. Cancer Treat Rep
71:915-919, 1987.
Hrushesky, W.J.M., Roemeling, Rv., Wood, P.A., Langevin, T.R.,
Lange, P. and Fraley, E. High-dose intensity systemic
therapy for metastatic bladder cancer. J Clin Oncol
5(3):450-455, 1987.
Hrushesky, W.J.M., Olshefski, R., Wood, P.A., Meshnick, S.,
Babson, J.R., Woods, W. and Eaton, J.W. Methylene blue
ameliorates doxorubicin toxicity. In: Superoxide and
Superoxide Dismutase in Chemistry, Biology and Medicine, G.
Rotilio (ed.), Proc. 4th Int'l Conf. on Superoxide and
Superoxide Dismutase, Rome, Italy, Elsevier, Amsterdam, pp.
642-646, 1986.
Hrushesky, W.J.M., Olshefski, R., Wood, P.A., Meshnick, S.
and Eaton, J.W. Modifying intracellular redox balance: an
approach to improving therapeutic index. Lancet Vol 1.
(March 9), 565-567, 1985.
Sanchez de la Peņa, S., Wood, P., Halberg, E., Cornelissen,
G., Eaton, J. and Halberg, F. Circadian and circaseptan
aspects of malarial infection and cyclosporine treatment in
mice. In: Ann Rev Chronopharmacology Vol 1, Reinberg, A.,
Smolensky, M. and Labrecque, G. (eds) Pergamon Press, New
York pp. 411-414, 1984.
Eaton, J.W. and Wood, P.A. Antimalarial red cells. In:
Progress in Clinical and Biological Research: Vol 165, The
Red Cell. Brewer, G. (ed.), Alan R. Liss Inc., New York pp.
395-412, 1984.
Wood, P.A., Rock, L. M. and Eaton, J.W. Chloroquine
resistance and host cell hemoglobin catabolism in Plasmodium
berghei. In: Progress in Clinical and Biological Research
Vol 155, Malaria and the Red Cell. Eaton, J.W. and Brewer,
G. (eds.), Alan R. Liss Inc., New York pp. 159-167, 1984.
Wiser, M.F., Wood, P.A., Eaton, J.W. and Sheppard, J.R.
Membrane-associated phosphoproteins in Plasmodium berghei
infected murine red cells. J Cell Biol 97:196-201, 1983.
Allen, D.W., Groat, J., Finkel, B., Wood, P.A. and Eaton,
J.W. Increased absorption of cytoplasmic proteins to the
erythrocyte membrane in ATP-depleted normal and pyruvate
kinase deficient mature cells and reticulocytes. Am J
Hematology 14:11-25,1983.
Tzannis ST, Hrushesky WJM, Wood PA and Przybycien TM.
Irreversible inactivation of interleukin-2 in a pump-based
delivery environment. Proc Natl Acad Sci USA 93:5460-5465,
1996. Wood, P.A. and Douglas, S.D. Development of chemotaxis
and formyl peptide binding in human promyelocytic leukemia
cell line (HL-60). Proc Soc Exp Biol Med 169:421-426, 1982.
For recent abstracts, click here
|
